Autosomal recessive spinocerebellar ataxia 9

From WikiMD's WELLNESSPEDIA

Alternate names[edit]

Autosomal recessive ataxia due to ubiquinone deficiency; ARCA2; Autosomal recessive ataxia due to coenzyme Q10 deficiency; Autosomal recessive cerebellar ataxia type 2; Autosomal recessive spinocerebellar ataxia type 9; SCAR9

Definition[edit]

This syndrome is characterised by childhood-onset progressive ataxia and cerebellar atrophy.

Epidemiology[edit]

Prevalence is unknown.

Cause[edit]

  • The syndrome is caused by ubiquinone deficiency.
  • Mutations in the ADCK3/CABC1 gene have been detected in affected individuals.
  • This gene is already known to play a role in ubiquinone biosynthesis in yeast.

Signs and symptoms[edit]

Exercise intolerance with elevated lactate levels and mild intellectual deficit may also be present.

For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. 80%-99% of people have these symptoms

  • Cerebellar atrophy(Degeneration of cerebellum)
  • Progressive cerebellar ataxia

30%-79% of people have these symptoms

  • Brisk reflexes
  • Central hypotonia
  • Developmental regression(Loss of developmental milestones)
  • Exercise intolerance(Decreased ability to exercise)
  • Focal T2 hypointense basal ganglia lesion
  • Intellectual disability, moderate(IQ between 34 and 49)
  • Proximal muscle weakness(Weakness in muscles of upper arms and upper legs)
  • Talipes cavus equinovarus

5%-29% of people have these symptoms

1%-4% of people have these symptoms

Diagnosis[edit]

Treatment[edit]

NIH genetic and rare disease info[edit]

Autosomal recessive spinocerebellar ataxia 9 is a rare disease.


WikiMD logo

This article is a stub

You can help WikiMD by registering and expanding it with useful details, internal links, formatting, and categories.

Editing is available only to registered and verified users. WikiMD is a comprehensive, free health and wellness encyclopedia.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.